The global Artificial Heart and Ventricular Assist Devices market size was valued at US$ million in 2023. With growing demand in downstream market, the Artificial Heart and Ventricular Assist Devices is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Artificial Heart and Ventricular Assist Devices market. Artificial Heart and Ventricular Assist Devices are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Artificial Heart and Ventricular Assist Devices. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Artificial Heart and Ventricular Assist Devices market.
An artificial heart is a device that replaces the heart. Artificial hearts are typically used to bridge the time to heart transplantation, or to permanently replace the heart in case heart transplantation is impossible. A ventricular assist device (VAD) — also known as a mechanical circulatory support device — is an implantable mechanical pump that helps pump blood from the lower chambers of your heart (the ventricles) to the rest of your body. A VAD is used in people who have weakened hearts or heart failure.
Key Features:
The report on Artificial Heart and Ventricular Assist Devices market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Artificial Heart and Ventricular Assist Devices market. It may include historical data, market segmentation by Type (e.g., Artificial Heart, Ventricular Assist Devices), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Artificial Heart and Ventricular Assist Devices market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Artificial Heart and Ventricular Assist Devices market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Artificial Heart and Ventricular Assist Devices industry. This include advancements in Artificial Heart and Ventricular Assist Devices technology, Artificial Heart and Ventricular Assist Devices new entrants, Artificial Heart and Ventricular Assist Devices new investment, and other innovations that are shaping the future of Artificial Heart and Ventricular Assist Devices.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Artificial Heart and Ventricular Assist Devices market. It includes factors influencing customer ' purchasing decisions, preferences for Artificial Heart and Ventricular Assist Devices product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Artificial Heart and Ventricular Assist Devices market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Artificial Heart and Ventricular Assist Devices market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Artificial Heart and Ventricular Assist Devices market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Artificial Heart and Ventricular Assist Devices industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Artificial Heart and Ventricular Assist Devices market.
Market Segmentation:
Artificial Heart and Ventricular Assist Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Artificial Heart
Ventricular Assist Devices
Segmentation by application
Coronary Heart Disease
Cerebrovascular Disease
Peripheral Arterial Disease
Rheumatic Heart Disease
Congenital Heart Disease
Deep Vein Thrombosis
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
SynCardia Systems
Medtronic PLC
Abbott Laboratories
BiVACOR
Berlin Heart
ABIOMED
LivaNova PLC
CARMAT
Jarvik Heart Inc
Chongqing Yongrenxin Medical
Thoratec
Cleveland Heart
CryoLife
Key Questions Addressed in this Report
What is the 10-year outlook for the global Artificial Heart and Ventricular Assist Devices market?
What factors are driving Artificial Heart and Ventricular Assist Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artificial Heart and Ventricular Assist Devices market opportunities vary by end market size?
How does Artificial Heart and Ventricular Assist Devices break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Heart and Ventricular Assist Devices Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Artificial Heart and Ventricular Assist Devices by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Artificial Heart and Ventricular Assist Devices by Country/Region, 2019, 2023 & 2030
2.2 Artificial Heart and Ventricular Assist Devices Segment by Type
2.2.1 Artificial Heart
2.2.2 Ventricular Assist Devices
2.3 Artificial Heart and Ventricular Assist Devices Sales by Type
2.3.1 Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Type (2019-2024)
2.3.2 Global Artificial Heart and Ventricular Assist Devices Revenue and Market Share by Type (2019-2024)
2.3.3 Global Artificial Heart and Ventricular Assist Devices Sale Price by Type (2019-2024)
2.4 Artificial Heart and Ventricular Assist Devices Segment by Application
2.4.1 Coronary Heart Disease
2.4.2 Cerebrovascular Disease
2.4.3 Peripheral Arterial Disease
2.4.4 Rheumatic Heart Disease
2.4.5 Congenital Heart Disease
2.4.6 Deep Vein Thrombosis
2.4.7 Other
2.5 Artificial Heart and Ventricular Assist Devices Sales by Application
2.5.1 Global Artificial Heart and Ventricular Assist Devices Sale Market Share by Application (2019-2024)
2.5.2 Global Artificial Heart and Ventricular Assist Devices Revenue and Market Share by Application (2019-2024)
2.5.3 Global Artificial Heart and Ventricular Assist Devices Sale Price by Application (2019-2024)
3 Global Artificial Heart and Ventricular Assist Devices by Company
3.1 Global Artificial Heart and Ventricular Assist Devices Breakdown Data by Company
3.1.1 Global Artificial Heart and Ventricular Assist Devices Annual Sales by Company (2019-2024)
3.1.2 Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Company (2019-2024)
3.2 Global Artificial Heart and Ventricular Assist Devices Annual Revenue by Company (2019-2024)
3.2.1 Global Artificial Heart and Ventricular Assist Devices Revenue by Company (2019-2024)
3.2.2 Global Artificial Heart and Ventricular Assist Devices Revenue Market Share by Company (2019-2024)
3.3 Global Artificial Heart and Ventricular Assist Devices Sale Price by Company
3.4 Key Manufacturers Artificial Heart and Ventricular Assist Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artificial Heart and Ventricular Assist Devices Product Location Distribution
3.4.2 Players Artificial Heart and Ventricular Assist Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Artificial Heart and Ventricular Assist Devices by Geographic Region
4.1 World Historic Artificial Heart and Ventricular Assist Devices Market Size by Geographic Region (2019-2024)
4.1.1 Global Artificial Heart and Ventricular Assist Devices Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Artificial Heart and Ventricular Assist Devices Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Artificial Heart and Ventricular Assist Devices Market Size by Country/Region (2019-2024)
4.2.1 Global Artificial Heart and Ventricular Assist Devices Annual Sales by Country/Region (2019-2024)
4.2.2 Global Artificial Heart and Ventricular Assist Devices Annual Revenue by Country/Region (2019-2024)
4.3 Americas Artificial Heart and Ventricular Assist Devices Sales Growth
4.4 APAC Artificial Heart and Ventricular Assist Devices Sales Growth
4.5 Europe Artificial Heart and Ventricular Assist Devices Sales Growth
4.6 Middle East & Africa Artificial Heart and Ventricular Assist Devices Sales Growth
5 Americas
5.1 Americas Artificial Heart and Ventricular Assist Devices Sales by Country
5.1.1 Americas Artificial Heart and Ventricular Assist Devices Sales by Country (2019-2024)
5.1.2 Americas Artificial Heart and Ventricular Assist Devices Revenue by Country (2019-2024)
5.2 Americas Artificial Heart and Ventricular Assist Devices Sales by Type
5.3 Americas Artificial Heart and Ventricular Assist Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Heart and Ventricular Assist Devices Sales by Region
6.1.1 APAC Artificial Heart and Ventricular Assist Devices Sales by Region (2019-2024)
6.1.2 APAC Artificial Heart and Ventricular Assist Devices Revenue by Region (2019-2024)
6.2 APAC Artificial Heart and Ventricular Assist Devices Sales by Type
6.3 APAC Artificial Heart and Ventricular Assist Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Artificial Heart and Ventricular Assist Devices by Country
7.1.1 Europe Artificial Heart and Ventricular Assist Devices Sales by Country (2019-2024)
7.1.2 Europe Artificial Heart and Ventricular Assist Devices Revenue by Country (2019-2024)
7.2 Europe Artificial Heart and Ventricular Assist Devices Sales by Type
7.3 Europe Artificial Heart and Ventricular Assist Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artificial Heart and Ventricular Assist Devices by Country
8.1.1 Middle East & Africa Artificial Heart and Ventricular Assist Devices Sales by Country (2019-2024)
8.1.2 Middle East & Africa Artificial Heart and Ventricular Assist Devices Revenue by Country (2019-2024)
8.2 Middle East & Africa Artificial Heart and Ventricular Assist Devices Sales by Type
8.3 Middle East & Africa Artificial Heart and Ventricular Assist Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artificial Heart and Ventricular Assist Devices
10.3 Manufacturing Process Analysis of Artificial Heart and Ventricular Assist Devices
10.4 Industry Chain Structure of Artificial Heart and Ventricular Assist Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artificial Heart and Ventricular Assist Devices Distributors
11.3 Artificial Heart and Ventricular Assist Devices Customer
12 World Forecast Review for Artificial Heart and Ventricular Assist Devices by Geographic Region
12.1 Global Artificial Heart and Ventricular Assist Devices Market Size Forecast by Region
12.1.1 Global Artificial Heart and Ventricular Assist Devices Forecast by Region (2025-2030)
12.1.2 Global Artificial Heart and Ventricular Assist Devices Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Artificial Heart and Ventricular Assist Devices Forecast by Type
12.7 Global Artificial Heart and Ventricular Assist Devices Forecast by Application
13 Key Players Analysis
13.1 SynCardia Systems
13.1.1 SynCardia Systems Company Information
13.1.2 SynCardia Systems Artificial Heart and Ventricular Assist Devices Product Portfolios and Specifications
13.1.3 SynCardia Systems Artificial Heart and Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 SynCardia Systems Main Business Overview
13.1.5 SynCardia Systems Latest Developments
13.2 Medtronic PLC
13.2.1 Medtronic PLC Company Information
13.2.2 Medtronic PLC Artificial Heart and Ventricular Assist Devices Product Portfolios and Specifications
13.2.3 Medtronic PLC Artificial Heart and Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Medtronic PLC Main Business Overview
13.2.5 Medtronic PLC Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories Artificial Heart and Ventricular Assist Devices Product Portfolios and Specifications
13.3.3 Abbott Laboratories Artificial Heart and Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 BiVACOR
13.4.1 BiVACOR Company Information
13.4.2 BiVACOR Artificial Heart and Ventricular Assist Devices Product Portfolios and Specifications
13.4.3 BiVACOR Artificial Heart and Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 BiVACOR Main Business Overview
13.4.5 BiVACOR Latest Developments
13.5 Berlin Heart
13.5.1 Berlin Heart Company Information
13.5.2 Berlin Heart Artificial Heart and Ventricular Assist Devices Product Portfolios and Specifications
13.5.3 Berlin Heart Artificial Heart and Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Berlin Heart Main Business Overview
13.5.5 Berlin Heart Latest Developments
13.6 ABIOMED
13.6.1 ABIOMED Company Information
13.6.2 ABIOMED Artificial Heart and Ventricular Assist Devices Product Portfolios and Specifications
13.6.3 ABIOMED Artificial Heart and Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 ABIOMED Main Business Overview
13.6.5 ABIOMED Latest Developments
13.7 LivaNova PLC
13.7.1 LivaNova PLC Company Information
13.7.2 LivaNova PLC Artificial Heart and Ventricular Assist Devices Product Portfolios and Specifications
13.7.3 LivaNova PLC Artificial Heart and Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 LivaNova PLC Main Business Overview
13.7.5 LivaNova PLC Latest Developments
13.8 CARMAT
13.8.1 CARMAT Company Information
13.8.2 CARMAT Artificial Heart and Ventricular Assist Devices Product Portfolios and Specifications
13.8.3 CARMAT Artificial Heart and Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 CARMAT Main Business Overview
13.8.5 CARMAT Latest Developments
13.9 Jarvik Heart Inc
13.9.1 Jarvik Heart Inc Company Information
13.9.2 Jarvik Heart Inc Artificial Heart and Ventricular Assist Devices Product Portfolios and Specifications
13.9.3 Jarvik Heart Inc Artificial Heart and Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Jarvik Heart Inc Main Business Overview
13.9.5 Jarvik Heart Inc Latest Developments
13.10 Chongqing Yongrenxin Medical
13.10.1 Chongqing Yongrenxin Medical Company Information
13.10.2 Chongqing Yongrenxin Medical Artificial Heart and Ventricular Assist Devices Product Portfolios and Specifications
13.10.3 Chongqing Yongrenxin Medical Artificial Heart and Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Chongqing Yongrenxin Medical Main Business Overview
13.10.5 Chongqing Yongrenxin Medical Latest Developments
13.11 Thoratec
13.11.1 Thoratec Company Information
13.11.2 Thoratec Artificial Heart and Ventricular Assist Devices Product Portfolios and Specifications
13.11.3 Thoratec Artificial Heart and Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Thoratec Main Business Overview
13.11.5 Thoratec Latest Developments
13.12 Cleveland Heart
13.12.1 Cleveland Heart Company Information
13.12.2 Cleveland Heart Artificial Heart and Ventricular Assist Devices Product Portfolios and Specifications
13.12.3 Cleveland Heart Artificial Heart and Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Cleveland Heart Main Business Overview
13.12.5 Cleveland Heart Latest Developments
13.13 CryoLife
13.13.1 CryoLife Company Information
13.13.2 CryoLife Artificial Heart and Ventricular Assist Devices Product Portfolios and Specifications
13.13.3 CryoLife Artificial Heart and Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 CryoLife Main Business Overview
13.13.5 CryoLife Latest Developments
14 Research Findings and Conclusion
Ìý
Ìý
*If Applicable.
